Three young men detained in Moscow for throwing flares at US ambassador’s residenceWorld October 25, 22:02
Kremlin gives no comment on alleged US carte blanche to Russia for Aleppo operationRussian Politics & Diplomacy October 25, 21:44
German ARD TV channel to go any length to win case against Russian athlete — lawyerSport October 25, 21:24
Russian, German top diplomats discuss humanitarian situation in Aleppo — ministryRussian Politics & Diplomacy October 25, 20:09
Russia moves up to 40th place in Doing Business-2017 rating — World BankBusiness & Economy October 25, 20:04
Russia hopes to receive roadmap from IPC on Paralympic membership soonSport October 25, 20:03
Lukoil warns about fake "namesake" company in UKBusiness & Economy October 25, 19:39
Russia keeps urging West to set up wide coalition against terrorismRussian Politics & Diplomacy October 25, 19:37
The farthest shore: peaceful images of Russia's Primorsky KraiSociety & Culture October 25, 19:17
LONDON, June 14. /TASS/. Russian tennis star Maria Sharapova said she would file an appeal with the Court of Arbitration for Sports (CAS) against her two-year suspension, imposed last week by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations, Britain’s web portal Sky News reported on Tuesday.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.